P Tech v. Arthrex: Federal Circuit Affirms Unpatentability of Deformable Fastener Patent
P Tech, LLC appealed an invalidity determination for US9814453B2, a patent covering a deformable fastener system asserted against Arthrex, Inc. A unanimous Federal Circuit panel — Chief Judge Moore, Judge Prost, and Judge Reyna — affirmed the unpatentability ruling, ending the dispute after 530 days.
Federal Circuit closes P Tech’s deformable fastener patent challenge against Arthrex
P Tech, LLC brought this appeal to the United States Court of Appeals for the Federal Circuit (Case No. 24-1391) on January 26, 2024, challenging a prior determination that US9814453B2 — a patent directed to a deformable fastener system — was unpatentable. The respondent, Arthrex, Inc., is a prominent orthopedic device manufacturer whose product portfolio overlaps with the fixation technology at issue. The patent traces its application lineage to US13/871892.
The Federal Circuit issued a per curiam affirmance on July 9, 2025, with a three-judge panel comprising Chief Judge Moore, Judge Prost, and Judge Reyna finding no reversible error in the underlying unpatentability determination. The basis of termination is recorded as ‘Unpatentable,’ confirming the patent did not survive the validity challenge. For P Tech, the affirmance exhausts its appellate options at this court level. For Arthrex, the ruling removes the patent as an active enforcement threat.
The 530-day duration from filing to disposition is broadly consistent with Federal Circuit appeal timelines for patent validity matters. The per curiam format — rather than a signed, precedential opinion — suggests the panel viewed the outcome as sufficiently clear-cut to not warrant extended written analysis, though the public record does not disclose the precise grounds or claim-by-claim analysis underlying the affirmance. What drove the original unpatentability finding, and whether obviousness or anticipation was the primary basis, remains unspecified in the available public record.
Filing to Unpatentable in 530 days
530 days from filing to Federal Circuit affirmance — consistent with typical appeal resolution timelines
Federal Circuit affirms: what the unpatentability ruling means for both parties
What ‘AFFIRMED’ means at the Federal Circuit
An affirmance by the Federal Circuit means the appellate panel found no reversible error in the lower tribunal’s determination that US9814453B2 is unpatentable. The court does not re-examine the merits from scratch; it reviews for legal error or unsupported factual findings. A per curiam affirmance signals the panel considered the outcome sufficiently clear to forgo a detailed signed opinion, lending finality to the unpatentability conclusion.
No reversible error foundP Tech’s patent is cancelled — enforcement path closed
With the Federal Circuit affirming unpatentability, US9814453B2 no longer carries enforceable claim coverage. P Tech’s ability to assert this patent against Arthrex or any third party is extinguished. Further appeal would require a petition to the Supreme Court, a route rarely granted and statistically unlikely to succeed. The commercial value of this asset as a licensing or litigation instrument is effectively eliminated.
Patent unenforceableArthrex exits with the patent cancelled and no infringement exposure
Arthrex successfully defended the unpatentability determination through the Federal Circuit level. The affirmance removes US9814453B2 as a litigation risk for Arthrex’s deformable fastener and orthopedic fixation product lines. Competitors operating in the same technology space similarly benefit: a cancelled patent cannot be asserted against any party, creating open design space in the deformable fastener category.
Arthrex fully clearedCancelled patent opens design freedom in orthopedic fastener space
The affirmance of unpatentability has sector-wide implications for orthopedic device manufacturers working with deformable fastener and tissue fixation systems. Any claim scope that US9814453B2 previously cast over competitor products is now void. R&D teams and product counsel in the orthopedic fixation space should reassess freedom-to-operate analyses that previously flagged this patent as a risk, and monitor P Tech’s remaining portfolio for related continuation claims.
Design freedom expandedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | P Tech, LLC | Company | Orthopedic IP licensing entity — holder of US9814453B2 deformable fastener system patentSearch in Eureka ↗ |
| Defendant | Arthrex, Inc. | Company | Arthrex, Inc. — orthopedic device manufacturer and respondent in Federal Circuit appealSearch in Eureka ↗ |
| Plaintiff counsel | Robert M. Evans | Attorney | Counsel for P Tech, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Lewis Rice LLC | Law Firm | Representing P Tech, LLCSearch in Eureka ↗ |
| Defendant counsel | Justin J. Oliver | Attorney | Counsel for Arthrex, Inc.Search in Eureka ↗ |
| Defendant counsel | Megan S. Woodworth | Attorney | Counsel for Arthrex, Inc.Search in Eureka ↗ |
| Defendant counsel | Robert E. Bugg Partner | Attorney | Counsel for Arthrex, Inc.Search in Eureka ↗ |
| Defendant law firm | Venable LLP | Law Firm | Representing Arthrex, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The per curiam order — ‘AFFIRMED’ — is the Federal Circuit’s most compact form of disposition, indicating the three-judge panel unanimously found no reversible error warranting correction. At the appellate level, the standard of review typically affords deference to factual findings (clear error) while reviewing legal conclusions de novo. The ‘Unpatentable’ basis of termination confirms the underlying validity challenge succeeded on the merits. For P Tech, no further relief is available at this court; for Arthrex, the ruling provides durable protection against this patent asset.
US9814453B2 — Deformable Fastener System for Orthopedic Fixation
US9814453B2 (application number US13/871892) protects a deformable fastener system, a technology category central to orthopedic fixation procedures where implants must conform to or anchor within biological tissue. Deformable fastener technologies are used in procedures ranging from soft tissue repair to bone anchoring, and the patent’s claims likely cover structural or mechanical features of the fastener’s deformation behaviour during or after implantation. The application lineage suggests this patent is part of a broader P Tech IP programme in minimally invasive and fixation surgery technologies.
For orthopedic device manufacturers, deformable fastener patents represent a strategically sensitive claim category because the underlying mechanical principles apply across numerous product lines — from suture anchors to interference screws. P Tech has historically maintained an active IP licensing and litigation posture in orthopedic surgery technology. With US9814453B2 now confirmed unpatentable, competitors should nonetheless review related patents in the same family or from the same assignee, as continuation claims covering similar subject matter may still be active and enforceable.
Should you run an FTO against US9814453B2 and P Tech’s fastener patent family?
Although US9814453B2 has been confirmed unpatentable by the Federal Circuit, product teams and IP counsel working on deformable fastener systems, suture anchors, or orthopedic fixation devices should not treat this cancellation as a blanket clearance. P Tech’s portfolio likely includes continuation applications sharing the US13/871892 priority chain, and those related patents may carry claim scope that reads on current or planned product designs. An FTO review limited to this single patent number would be insufficient.
PatSnap Eureka’s FTO Search Agent can map the full US13/871892 patent family, identify live continuation and divisional applications, and flag claim language that overlaps with your device design parameters. Rather than manual docket searches across multiple jurisdictions, Eureka consolidates patent family trees, prosecution history, and litigation status in a single workflow — giving R&D and regulatory teams a defensible clearance record before product launch or market expansion in the orthopedic fixation space.
Run a freedom-to-operate analysis on US9814453B2 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit appeals: orthopedic device patent unpatentability rulings
Explore Federal Circuit cases involving orthopedic fixation and implant patents challenged on unpatentability grounds, including other P Tech assertions and Arthrex-related appeals.
What this case signals for the orthopedic fixation IP landscape
The Federal Circuit’s per curiam affirmance of unpatentability in P Tech v. Arthrex has practical consequences for patent strategy across the orthopedic device sector.
Per curiam affirmances signal weak appellate records — audit your portfolio
When the Federal Circuit issues a per curiam affirmance rather than a signed opinion, it typically signals the panel viewed the outcome as straightforward. Patent holders with similar deformable fastener or orthopedic fixation claims should audit their portfolios for analogous vulnerability, particularly around prior art that may have driven the underlying unpatentability finding.
Cancelled patents free design space — competitors should act now
With US9814453B2 confirmed unpatentable, orthopedic device companies developing deformable fastener systems face reduced IP friction in this claim space. However, P Tech may hold continuation or related patents covering adjacent embodiments. A targeted freedom-to-operate review of P Tech’s broader portfolio is advisable before product launches in this category.
P v Arthrex — key questions answered
The Federal Circuit affirmed the unpatentability of US9814453B2, a deformable fastener system patent asserted by P Tech, LLC against Arthrex, Inc. The per curiam order issued July 9, 2025 found no reversible error in the lower tribunal’s determination, ending P Tech’s appeal and permanently removing the patent as an enforceable asset.
US9814453B2, filed under application number US13/871892, is a patent assigned to P Tech, LLC covering a deformable fastener system. The technology relates to orthopedic fixation — specifically fastener designs that deform during or after implantation to anchor tissue or bone. The patent was the sole asset at issue in the Federal Circuit appeal against Arthrex, Inc.
A per curiam affirmance means the Federal Circuit panel unanimously found the lower unpatentability ruling free of reversible error without issuing a detailed signed opinion. For P Tech, this exhausts appellate relief at the Federal Circuit level. The patent is confirmed unpatentable and cannot be enforced against Arthrex or any other party. A Supreme Court petition would be the only remaining avenue, and such petitions are rarely granted in patent validity matters.
Yes. Because the patent was confirmed unpatentable — not merely held non-infringed — the cancellation benefits the entire industry. No company can be sued under US9814453B2 going forward. However, competitors should independently verify whether P Tech holds continuation or related patents covering similar claim scope before treating this ruling as a complete FTO clearance for deformable fastener products.
The public record identifies ‘Unpatentable’ as the basis of termination and characterises the proceeding as an Invalidity/Cancellation Action on Patentability grounds. However, the specific statutory basis — whether anticipation under 35 U.S.C. § 102, obviousness under § 103, or another ground — is not disclosed in the available case record. The per curiam format of the affirmance means no detailed written analysis of the prior art grounds was published.
PatSnap Eureka searches patents and litigation data to answer instantly.